Use access key #2 to skip to page content.
$73.03 0.57 (0.79%)
7/3/2008 1:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
*****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View All Commentary (GENZ)

Recs

1

Avatar extremeinvesting (96.95) Submitted: 11/01/06 11:19 AM : Outperform Start Price: $67.44 GENZ Score: 16.88

GENZ is an extreme performance investing stock with a niche in products that are targeted at rare and specific diseases, to include diagnostic products and services.

Report this Post Replies: 0 | Reply

Featured Broker Partners